SCHEMBL1123058

SCHEMBL1123058

COC(=O)c1ccc(OCCc2ccc3ccccc3c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
RAB9A P51151 3/20 0.62
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
POLB P06746 1/20 0.54
PPARG P37231 2/20 0.53
PPARD Q03181 2/20 0.53
PPARA Q07869 2/20 0.53
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 3/20 0.51
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MTNR1A P48039 1/20 0.49
MTNR1B P49286 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ADAM17 P78536 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791330 0.86 RAB9A (0.62) MAPTRAB9APOLBSMN1; SMN2NPC1
SCHEMBL7860388 0.86 MAPT (0.52) MAPTRAB9ATDP1L3MBTL1POLB
SCHEMBL1123048 0.85 PKM (0.61) PPARGPPARDPPARA
SCHEMBL4361298 0.84 MAPT (0.77) MAPTRAB9ATDP1L3MBTL1PPARG
SCHEMBL5392156 0.84 MAPT (0.77) MAPTRAB9ATDP1L3MBTL1PPARG
SCHEMBL2970662 0.83 POLB (0.46) MAPTRAB9ATDP1L3MBTL1POLB
SCHEMBL9268448 0.81 NPC1 (0.71) MAPTRAB9APOLBPPARGSMN1; SMN2
SCHEMBL9041562 0.81 PPARG (0.50) MAPTRAB9APPARGPPARDPPARA
SCHEMBL6382468 0.81 PPARG (0.81) PPARGPPARDPPARAADAM17
SCHEMBL9038241 0.80 MAPT (0.68) MAPTRAB9ATDP1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed
EP-1644321-A2 NEW BENZAMIDES AS PPATY MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-04-12 EP disclosed
WO-2004110983-A2 NEW BENZAMIDES AS PPARϒ MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG MAPT 4365/4885RAB9A 4567/4885TDP1 2561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.